Akero Therapeutics
AKRO54.6500.00% ( 0.000 )
Q3 FY2025 Earnings
Financial report interval: 2025.06.30 - 2025.09.30
Overview: Akero Therapeutics(AKRO) the EBIT is -90.24 M (-10.44%);the EPS is -0.995 (+5%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.09B10.44%
----
----
EPS
-0.99465.00%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf